SCHEDULE 13G: Investment Funds Disclose 6.1% Stake in Microbot Medical Inc.
Beneficial Ownership Report
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly reported a 6.1% beneficial ownership stake in Microbot Medical Inc., totaling 1,257,143 shares.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, "Reporting Persons") have filed a Schedule 13G with the SEC.
- The Reporting Persons beneficially own 1,257,143 shares of Microbot Medical Inc.'s common stock.
- This ownership represents 6.1% of the company's total outstanding common stock.
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and exercises shared voting and dispositive power over these shares.
- As of the completion of a recent offering referenced in a Prospectus Supplement filed on January 7, 2025, Microbot Medical Inc. had 20,651,434 shares outstanding.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's a routine disclosure, the presence of a significant institutional investor can be seen as a positive signal of confidence in the company, although no operational or financial performance details are provided.
Positives
- The disclosure of a significant institutional investor, CVI Investments, Inc., managed by Heights Capital Management, Inc., holding a substantial stake (6.1%) may signal confidence in Microbot Medical Inc.'s prospects.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding Microbot Medical Inc.'s future operations or financial performance, as it is solely an ownership disclosure.
Industry Context
This Schedule 13G filing indicates a significant institutional investment in Microbot Medical Inc., a company operating in the medical device sector. Such investments can signal investor confidence in the company's potential within its industry, particularly given the specialized nature of medical technology.
Comparison to Industry Standards
- This filing is a standard beneficial ownership disclosure and does not contain information for direct comparison to industry-specific operational or financial benchmarks. It primarily details an investment stake rather than company performance or project results.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor holding a 6.1% stake may increase investor confidence and potentially influence market perception of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 2023-12-04 | Date of Prospectus referenced in the filing. |
| 2025-01-06 | Date of event which required the filing of this statement (acquisition of beneficial ownership exceeding 5%). |
| 2025-01-07 | Date of filing of Microbot Medical Inc.'s Prospectus Supplement, indicating 20,651,434 shares outstanding. |
| 2025-01-13 | Date of signing and filing of this Schedule 13G statement. |
Keywords
Microbot Medical Inc., CVI Investments Inc., Heights Capital Management Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.